scholarly journals Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors

2015 ◽  
Vol 2 ◽  
pp. 15025 ◽  
Author(s):  
Peirong Hu ◽  
Yedda Li ◽  
Mark S Sands ◽  
Thomas McCown ◽  
Tal Kafri
Blood ◽  
2002 ◽  
Vol 100 (12) ◽  
pp. 3960-3967 ◽  
Author(s):  
Peter A. Horn ◽  
Max S. Topp ◽  
Julia C. Morris ◽  
Stanley R. Riddell ◽  
Hans-Peter Kiem

Vector-containing medium harvested from murine packaging cell lines has been shown to contain factors that can negatively influence the transduction and maintenance of hematopoietic stem cells. Thus, we generated a human packaging cell line with a gibbon ape leukemia virus pseudotype (Phoenix-GALV), and we evaluated vectors produced by Phoenix-GALV for their ability to transduce hematopoietic progenitor/stem cells. In 3 baboons, we used a competitive repopulation assay to directly compare GALV-pseudotype retrovirus vectors produced by either Phoenix-GALV or by the NIH 3T3–derived packaging cell line, PG13. In 3 additional baboons we compared Phoenix-GALV–derived vectors to more recently developed lentiviral vectors. Gene transfer efficiency into hematopoietic repopulating cells was assessed by evaluating the number of genetically modified peripheral blood and marrow cells using flow cytometry and real-time polymerase chain reaction. Transduction efficiency of hematopoietic repopulating cells was significantly higher using the Phoenix-GALV–derived vector as compared with the PG13-derived vectors or lentiviral vectors, with stable transduction levels up to 25%. We followed 2 animals for more than one year. Flow cytometric analysis of hematopoietic subpopulations in these animals revealed transgene expression in CD13+ granulocytes, CD20+ B lymphocytes, CD3+ T lymphocytes, CD61+ platelets, as well as red blood cells, indicating multilineage engraftment of cells transduced by Phoenix-GALV–pseudotype vectors. In addition, transduction of human CD34+ cells was significantly more efficient than transduction of baboon CD34+ cells, suggesting that Phoenix-GALV–derived oncoretroviral vectors may be even more efficient in human stem cell gene therapy applications.


2006 ◽  
Vol 14 (2) ◽  
pp. 276-284 ◽  
Author(s):  
Adam S. Cockrell ◽  
Hong Ma ◽  
Kailing Fu ◽  
Thomas J. McCown ◽  
Tal Kafri

2013 ◽  
Vol 24 (4) ◽  
pp. 228-240 ◽  
Author(s):  
Anna Stornaiuolo ◽  
Bianca Maria Piovani ◽  
Sergio Bossi ◽  
Eleonora Zucchelli ◽  
Stefano Corna ◽  
...  

1999 ◽  
Vol 73 (1) ◽  
pp. 576-584 ◽  
Author(s):  
Tal Kafri ◽  
Henriette van Praag ◽  
Ling Ouyang ◽  
Fred H. Gage ◽  
Inder M. Verma

ABSTRACT Lentivirus vectors can transduce dividing and nondividing cells. Using three-plasmid transient transfections, high-titer (>109 IU/ml) recombinant lentivirus vectors pseudotyped with vesicular stomatitis virus G (VSV-G) protein can be generated (T. Kafri et al., Nat. Genet. 17:314–317, 1997; H. Miyoshi et al., Proc. Natl. Acad. Sci. USA 94:10319–10323, 1997; L. Naldini et al., Science 272:263–267, 1996). The recombinant lentiviruses can efficiently infect brain, liver, muscle, and retinal tissue in vivo. Furthermore, the transduced tissues demonstrated long-term expression of reporter genes in immunocompetent rodents. We now report the generation of a tetracycline-inducible VSV-G pseudotyped lentivirus packaging cell line which can generate virus particles at titers greater than 106 IU/ml for at least 3 to 4 days. The vector produced by the inducible cell line can be concentrated to titers of 109 IU/ml and can efficiently transduce nondividing cells in vitro and in vivo. The availability of a lentivirus packaging cell line will significantly facilitate the production of high-titer lentivirus vectors for gene therapy and study of human immunodeficiency virus biology.


2001 ◽  
Vol 12 (8) ◽  
pp. 981-997 ◽  
Author(s):  
Deborah Farson ◽  
Rochelle Witt ◽  
Ryan McGuinness ◽  
Tom Dull ◽  
Michael Kelly ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document